GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma

Glutathione peroxidase 2 has important role of tumor progression in lots of carcinomas, yet little is known about the prognosis of glutathione peroxidase 2 in hepatocellular carcinoma. Glutathione peroxidase 2 expression was assessed by immunohistochemistry in hepatocellular carcinoma tissues. The a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ting Liu, Xue-feng Kan, Charlie Ma, Li-li Chen, Tian-tian Cheng, Zhen-wei Zou, Yong Li, Feng-jun Cao, Wen-jie Zhang, Jing Yao, Pin-dong Li
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-06-01
Series:	Tumor Biology
Online Access:	https://doi.org/10.1177/1010428317700410
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis
by: Rui-Qing Zong, et al.
Published: (2022-01-01)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
by: Cheng‐Qian Zhong, et al.
Published: (2018-06-01)

CCDC138 overexpression predicts poor prognosis and highlights ciliopathy-linked mechanisms in uterine corpus endometrial carcinoma
by: Aiping Wang, et al.
Published: (2025-08-01)

Membranous Overexpression of Fibronectin Predicts Microvascular Invasion and Poor Survival Outcomes in Patients with Hepatocellular Carcinoma
by: Yoon Jung Hwang, et al.
Published: (2025-03-01)

Overexpression of CPEB4 in glioma indicates a poor prognosis by promoting cell migration and invasion
by: Liu Zhijun, et al.
Published: (2017-04-01)

ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma
by: Liyan Wu, et al.
Published: (2025-04-01)

MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma
by: Zhihua Yao, et al.
Published: (2017-05-01)

MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
by: Lin-Lin Tian, et al.
Published: (2021-01-01)

Mortalin overexpression predicts poor prognosis in early stage of non–small cell lung cancer
by: Jie Sun, et al.
Published: (2017-03-01)

Overexpression of MMP14 is associated with poor prognosis and immune cell infiltration in colon cancer
by: Na Li, et al.
Published: (2025-04-01)

High expression of BBOX1 in paracancerous tissue is associated with poor prognosis in hepatocellular carcinoma patients
by: Runqi Fang, et al.
Published: (2024-11-01)

Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
by: Yuanyuan Chen, et al.
Published: (2016-01-01)

Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma
by: Run Shi, et al.
Published: (2017-03-01)

Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
by: Fang Liu, et al.
Published: (2014-01-01)

The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma
by: Yuhang Pan, et al.
Published: (2017-03-01)

A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41
by: Zihan Mu, et al.
Published: (2025-05-01)

RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization
by: Siyuan Wu, et al.
Published: (2025-01-01)

Correction: Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
by: Xuewen Liu, et al.
Published: (2025-04-01)

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma
by: Liang Yang, et al.
Published: (2025-03-01)

Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
by: Zhongchao Zhang, et al.
Published: (2025-03-01)

The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma
by: Jianzhong Cao, et al.
Published: (2017-05-01)

SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
by: Ying-Ming Xu, et al.
Published: (2025-07-01)

Mesenchymal Stem Cells with Simultaneous Overexpression of GPX3 and CD47 for the Treatment of Drug-Induced Acute Liver Injury
by: Yuanxiang Jing, et al.
Published: (2025-02-01)

Lower serum GPX4 and GSH/GSSG ratio are associated with poor prognosis in severe community-acquired pneumonia
by: Wei Zhu, et al.
Published: (2025-08-01)

Selective identification of polyploid hepatocellular carcinomas with poor prognosis by artificial intelligence-based pathological image recognition
by: Takanori Matsuura, et al.
Published: (2025-07-01)

Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells
by: Haoying Yang, et al.
Published: (2024-11-01)

Monotropein Induced Ferroptosis to Alleviate the Progression of Hepatocellular Carcinoma via Regulating Nrf2/HO‐1/GPX4 Axis
by: Bing Shi, et al.
Published: (2025-08-01)

High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes
by: Meng Pu, et al.
Published: (2017-07-01)

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
by: Su-xia Han, et al.
Published: (2014-01-01)

Elevation of Hepatic Selenoprotein K in Glutathione Peroxidase-1 Overexpressing Mice Was Unlikely Mediated by the GPX1 Protein per Se
by: Chenhan Feng, et al.
Published: (2025-05-01)

and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma
by: Xiaojie Liang, et al.
Published: (2025-02-01)

Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus
by: Wei-Chen Kao, et al.
Published: (2025-04-01)

PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer
by: Xue-fei Wang, et al.
Published: (2022-11-01)

Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression
by: Hai Zhu, et al.
Published: (2024-12-01)

Clinical value of inflammatory indices in predicting poor prognosis and post-hemorrhagic hydrocephalus in patients with intraventricular hemorrhage
by: Haoxiang Wang, et al.
Published: (2025-03-01)

HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer
by: Yixuan Wang, et al.
Published: (2017-07-01)

Mechanisms of HRAS regulation of liver hepatocellular carcinoma for prognosis prediction
by: Xingbao Fang, et al.
Published: (2025-04-01)

ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
by: Yang Luo, et al.
Published: (2015-01-01)

Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma
by: Shu-Xian Li, et al.
Published: (2025-05-01)